share_log

A股异动丨寒武纪拉升涨超6%再创历史新高,市值突破2800亿,业内人士提示风险

A-shares fluctuations丨Cervical Cancer rose more than 6% to set a new historical high, Market Cap surpassing 280 billion, industry insiders warn of risks.

Gelonghui Finance ·  Dec 20 10:32

Gelonghui, December 20 | Continuing its recent strong momentum, Cambricon (688256.SH) rose again today, at one point increasing over 6% to 676.77 yuan, setting a new historical high stock price, with a market cap exceeding 280 billion yuan; the stock has surged 400% this year. Regarding the frantic speculation by investors, some analysts believe that, in addition to being stimulated by U.S. chip stocks, the recent adjustments in major indices have also contributed to Cambricon's explosive growth. On November 29, the China Securities Index Company announced the periodic adjustment plan for the SSE 50 Index sample. Cambricon has been added to the SSE 50 Index, and the new index sample will take effect after the market closes on December 13, 2024. Additionally, the CSI A500 Index also underwent its first adjustment, replacing 21 sample stocks, which will officially take effect after the market closes on December 13, 2024. The included constituent stocks include Cambricon and BEIGENE among four stocks with trillion market cap. While the stock price continues to reach new highs, some analysts remind that there is a significant divergence between Cambricon's performance and stock price. Cambricon has reported losses for consecutive years from 2020 to 2023 since its listing.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment